The Growing Pharmacovigilance Industry & Its Impact on Life Science Enterprises & Service Providers

In this video, Ankur Verma, Practice Director, and Gokul Janardhan, Senior Analyst, discuss the pharmacovigilance industry and how it’s become a significant market in terms of spend from life science enterprises, currently a US$19 billion market. Life science enterprises are now looking more at third party services to support and manage pharmacovigilance operations across the entire value chain.

Learn more in our viewpoint, The Evolving Pharmacovigilance (PV) Landscape.

Discover current challenges that life science enterprises are facing and what is driving this growth in the pharmacovigilance industry throughout this video.

How can we engage?

Please let us know how we can help you on your journey.

Contact Us

"*" indicates required fields

Please review our Privacy Notice and check the box below to consent to the use of Personal Data that you provide.